WS08.03: Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor/tezacaftor/ivacaftor therapy

H. Gavillet^*, L. Hatfield, M. Hardman, G.G. Einarsson, C.S. Thornton, M.D. Parkins, J. Duckers, J.M. Bomberger, Y. Hilliam, S.E. Lee, R.W. Lord, A. Jones, A. Horsley, T.W.V. Daniels, C.C. Teneback, M.J. Wargo, K. Schutz, D.W. Rivett, C. van der Gast

^*Corresponding author for this work

Research output: Contribution to journal › Meeting Abstract › peer-review

1 Article

1 results

2026
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor–tezacaftor–ivacaftor therapy
van der Gast, C., Gavillet, H., Hatfield, L. R., Hardman, M., Marsh, R., Einarsson, G. G., Thornton, C. S., Parkins, M. D., Duckers, J., Bomberger, J. M., Hilliam, Y., Lee, S. E., Lord, R. W., Jones, A., Horsley, A., Daniels, T. W. V., Teneback, C. C. & Rivett, D. W., 30 May 2026, (E-pub ahead of print) In: Microbiome.
Research output: Contribution to journal › Article › peer-review

Open Access
File
37 Downloads (Pure)

WS08.03: Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor/tezacaftor/ivacaftor therapy

Research output

Search results

2026

Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor–tezacaftor–ivacaftor therapy